The company declared a dividend for shareholders that was paid on Tuesday the 15th of August 2017. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a research report on Friday, June 30th. Aug 7, 2017 is the announcement. The stock increased 0.66% or $0.25 during the last trading session, reaching $38.25. About shares traded. McDonald’s Corporation (NYSE:MCD) has risen 18.25% since September 26, 2016 and is uptrending. First Citizens Bank & Trust Co. bought a new position in shares of Colgate-Palmolive in the first quarter worth about $563,000.
After touching a high of Rs.1091.85 and dropping as low as Rs.1068.00 through the day, one stock of Colgate Palmolive (India) was observed to be priced at Rs.1073.85. In the most recent quarter, institutional ownership decreased by a net of 4.38 million shares, or 0.67%. Colgate Palmolive now has $62.71B valuation. The stock decreased 1.67% or $2.65 during the last trading session, reaching $156.26.
Colgate-Palmolive Company (NYSE:CL) is another stock that is grabbing investors attention these days. It has underperformed by 10.47% the S&P500. It tells an investor how quickly a company is increasing its revenues. Its up 0.09, from 1.04 in 2017Q1. It is positive, as 47 investors sold CL shares while 453 reduced holdings. 92 funds opened positions while 359 raised stakes. During the same quarter in the prior year, the firm posted $0.70 earnings per share. 8,740 are owned by Focused Wealth Inc. Harbour Invest Management Limited Liability Corp invested in 0.92% or 17,050 shares. Cwm Limited Liability Company reported 0.01% in Colgate-Palmolive Company (NYSE:CL). 520 were reported by Grisanti Cap Management Ltd Liability. First Fincl Bank holds 0.02% in Colgate-Palmolive Company (NYSE:CL) or 3,558 shares. Wunderlich Managemnt stated it has 1.04% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Over the last three months, the stock has dropped about 3.1%, but it has performed well overall in the current calendar year, popping 12.5%. Hm Payson And Co owns 157,919 shares for 0.53% of their portfolio. Aberdeen Asset Mgmt Public Limited Company Uk holds 0.15% of its portfolio in McDonald’s Corporation (NYSE:MCD) for 297,757 shares. Voya Inv Mngmt Limited Liability Corp owns 65,073 shares. California State Teachers Retirement Systems stated it has 254,600 shares or 0% of all its holdings.
The RSI (Relative Strength Index), an indicator that shows price strength by comparing upward and downward close-to-close movements is 63.07 for Colgate-Palmolive Company (NYSE:CL). They are also projecting the Low EPS estimate of $0.71 and the High EPS estimate of $0.75. The stock of Colgate-Palmolive Company (NYSE:CL) has “Hold” rating given on Thursday, July 6 by Jefferies. Macquarie started coverage on Colgate-Palmolive in a research report on Thursday, September 14th. The rating was maintained by RBC Capital Markets on Tuesday, August 1 with “Hold”. The ROIC Quality of Colgate-Palmolive Company (NYSE:CL) is 13.005511.
A number of equities research analysts have issued reports on CL shares. The firm has “Buy” rating by Northland Capital given on Friday, July 14. The stock of Colgate-Palmolive Company (NYSE:CL) earned “Neutral” rating by Sterne Agee CRT on Friday, February 26. The company was maintained on Monday, January 30 by Stifel Nicolaus. The current consensus recommendation provided by covering analysts is 2.00. This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC. ZIXI’s profit will be $1.66M for 39.83 P/E if the $0.03 EPS becomes a reality. Brands (NYSE:YUM) stake by 199,889 shares and now owns 59,411 shares. It also reduced Enbridge (NYSE:ENB) stake by 75,769 shares and now owns 25,914 shares. Dow Chem Co (NYSE:DOW) was raised too. An M-Score more than -2.22 suggests that the company is likely to be a manipulator. Given that liquidity is king in short-term, RTTR is a stock with 15.37 million shares outstanding that normally trades 12.25% of its float.
Analyst Recommendations are opinions given by analysts to their clients about whether a given stock is worth buying or not. Therefore 14% are positive. The price now stands at $73.69.
Analysts await Antares Pharma Inc (NASDAQ:ATRS) to report earnings on November, 8. H.C. Wainwright has “Buy” rating and $500 target. The rating was upgraded by BNP Paribas to “Outperform” on Monday, January 18. As per Monday, September 12, the company rating was upgraded by Bank of America. The company was initiated on Friday, September 9 by KeyBanc Capital Markets. Goldman Sachs upgraded the stock to “Neutral” rating in Monday, May 2 report. Citigroup maintained the stock with “Buy” rating in Friday, July 29 report.
Since June 7, 2017, it had 0 buys, and 1 sale for $89,464 activity.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our daily email newsletter.